1 |
Kim TW, Lee TY, Bae HC, Hahm JH, Kim YH, Park C, et al. 2007. Oral administration of high molecular mass poly-gamma-glutamate induces NK cell-mediated antitumor immunity. J. Immunol. 179: 775-780.
DOI
|
2 |
Lee TY, Kim YH, Yoon SW, Choi JC, Yang JM, Kim CJ, et al. 2009. Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect. Cancer Immunol. Immunother. 58: 1781-1794.
DOI
|
3 |
Park HJ, Zhang N, Park DK. 2011. Topical application of Polygonum multiflorum extract induces hair growth of resting hair follicles through upregulating Shh and beta-catenin expression in C57BL/6 mice. J. Ethnopharmacol. 135: 369-375.
DOI
ScienceOn
|
4 |
Lim YT, Shim SM, Noh YW, Lee KS, Choi DY, Uyama H, et al. 2011. Bioderived polyelectrolyte nanogels for robust antigen loading and vaccine adjuvant effects. Small 7: 3281-3286.
DOI
ScienceOn
|
5 |
Moon HJ, Lee JS, Choi YK, Park JY, Talactac MR, Chowdhury MYE, et al. 2012. Induction of type I interferon by high-molecular poly-γ-glutamate protects B6.A2G-Mx1 mice against influenza A virus. Antiviral Res. 94: 98-102.
DOI
ScienceOn
|
6 |
Park C, Sung MH. 2009. New bioindustrial development of high molecular weight of poly-gamma-glutamic acid produced by Bacillus subtilis (Chungkookjang). Polym. Sci. Technol. 20: 440-446.
|
7 |
Shin HS, Lee JM, Park SY. 2013. Hair growth activity of Crataegus pinnatifida on C57BL/6 mouse model. Phytother. Res. 27: 1352-1357.
DOI
ScienceOn
|
8 |
Stefanato CM. 2010. Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology 56: 24-38.
DOI
ScienceOn
|
9 |
Stenn KS, Paus R. 2001. Controls of hair follicle cycling. Physiol. Rev. 71: 450-481.
|
10 |
Adam ET, Tokarz D, Prent N, Cisek R, Alami J, Dumont DJ, et al. 2010. Nonlinear multicontrast microscopy of hematoxylinand-eosin-stained histological sections. J. Biomed. Opt. 15: 026018.
DOI
ScienceOn
|
11 |
Gordon KA, Tosti A. 2011. Alopecia: evaluation and treatment. Clin. Cosmet. Investig. Dermatol. 4: 101-106.
DOI
ScienceOn
|
12 |
Ashiuchi M, Kamei T, Baek DH, Shin SY, Sung MH, Soda K, et al. 2001. Isolation of Bacillus subtilis (Chungkookjang), a poly-gamma-glutamate producer with high genetic competence. Appl. Microbiol. Biotechnol. 57: 764-769.
DOI
|
13 |
D’Amico AV, Roehrborn CG. 2007. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Lancet Oncol. 8: 21-25.
DOI
ScienceOn
|
14 |
Gelfuso GM, Gratieri T, Delgado-Charro MB, Guy RH, Vianna Lopez RF. 2013. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia. J. Pharm. Sci. 102: 1488-1494.
DOI
ScienceOn
|
15 |
Gregoriou S, Papafragkaki D, Kontochristopoulos G, Rallis E, Kalogeromitros D, Rigopoulos D. 2010. Cytokines and other mediators in alopecia areata. Mediators Inflamm. 2010: 928030.
|
16 |
Hillmann K, Blume-Peytavi U. 2009. Diagnosis of hair disorders. Semin. Cutan. Med. Surg. 28: 33-38.
DOI
ScienceOn
|
17 |
Kaufman KD, Dawber RP. 1999. Finasteride, a Type 2 5 alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia. Expert Opin. Investig. Drugs 8: 403-415.
DOI
ScienceOn
|
18 |
Tosti A, Piraccini BM, Sisti A, Duque-Estrada B. 2009. Hair loss in women. Minerva Ginecol. 61: 445-452.
|
19 |
Sun ZY, Tu ZH. 1998. A novel in vitro model to screen steroid 5 alpha-reductase inhibitors against benign prostatic hyperplasia. Methods Find Exp. Clin. Pharmacol. 20: 283-287.
DOI
|
20 |
Tarlow JK, Clay FE, Cork MJ. 1994. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J. Invest. Dermatol. 103: 387-390.
DOI
ScienceOn
|
21 |
Wosicka H, Cal K. 2010. Targeting to the hair follicles: current status and potential. J. Dermatol. Sci. 57: 83-89.
DOI
ScienceOn
|
22 |
Zhao J, Harada N, Okajima K. 2011. Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin-like growth factor-I production in dermal papillae. Growth Horm. IGF Res. 21: 260-267.
DOI
ScienceOn
|